Description Adyen N.V. operates a payments platform that integrates payments stack. The company provides gateway, risk management, processing, acquiring, and settlement services. It offers a back-end infrastructure for authorizing payments across merchants' sales channels i.e. online, mobile, and in-store, as well as APIs. The payments platform is provided as a service to a range of merchants across various verticals, connecting them directly to Visa, Mastercard, and other payment methods and providing data insights. The company has offices in the Netherlands, Brazil, Singapore, the United Kingdom, Canada, Australia, South Korea, Hong Kong, Mexico, China, New Zealand, Malaysia, India, Japan, and the United States, with branches in Germany, France, and Sweden, as well as representative offices in Belgium, Italy, and Spain. Adyen N.V. was founded in 2006 and is based in Amsterdam, the Netherlands.
<<<WATCH LIST>>> AMTX-- Found this on Yahoo 6 hours ago WARNING: they have 70k cash in their balance sheets, they will make a stock offering as soon as they can, do not buy at these levels or you will lose 40% of your investment in a matter of days. They desperately need to raise funds, and they will do it as soon as possible. XPEV-- COLL-- CVAC-- ST-- SNAP-- ACCD-- PINS--
Look at the money this guy made- The Last 12 Months Of Insider Transactions At CureVac Over the last year, we can see that the biggest insider purchase was by insider Dietmar Hopp for US$124m worth of shares, at about US$16.00 per share. Even though the purchase was made at a significantly lower price than the recent price (US$109), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price. I mean give him credit that's a large bet he made.
Wow talk about a comeback story for our Shrimp guys-- that new factory that's because... On March 18, 2020, Natural Shrimp is dealt a devastating blow as their production facility is destroyed by a fire caused by a natural gas leak. This was a very unfortunate event. The stock price dropped roughly 70% over 2 days before settling just north of .02/share.
It sounds like they just circulate sea water vs regular.. but there must be more to it. In the year 2020, NaturalShrimp and their partnership with F&T Water Solutions, LLC developed their RAS utilizes ORP and anti-oxidation treatments, and electrocoagulation to eliminate harmful pathogens and waste that traditionally handicap tank raised shrimp aquaculture. Their process continuously cycles ocean equivalent salt water that keeps their shrimp populations bacteria, virus, and disease free. They also utilize an automatic feeding system that reduces labor costs, and uses data analytics to provide the ideal amount of feed to their shrimp populations which improves growth rates, health, and reduces costs associated with overfeeding. All of the above is completely natural and free of antibiotics and chemicals. NaturalShrimp harvest rates (via meticulous testing and trials) exceeds a 98% success rate. This dwarfs the historical average of 50-70%. Smaller operations can see successful harvest rates at 85% or more on average, however, these are not scalable to mass production.
OK VAN THIS IS IT!!! I RECENTLY BOUGHT DRAGANFLY DRONE..... AND NOW I REALIZE WHY I DID!!!-DFLYF> Back on January 6th, the FAA added 12 members to the Drone Advisory Committee. It consisted of folks who, as traders, we should pay more attention to but often don't. Drones are set to become a bigger and bigger part of the commercial world and our day-to-day lives. One name on the list did catch my eye on a second pass: Molly Wilkinson. She's the VP of regulatory affairs at American Airlines (AAL) , but I'm not looking at AAL stock here. They aren't much of a player in the drone world. But if you check out the Draganfly (DFLYF) Advisory Board, you'll find her name as a member. That tie is intriguing. Of course, it doesn't guarantee anything, but it never hurts to have a woman on the inside that can help steer the company in the most efficient direction. It's worth noting as well that Draganfly announced two days ago it had begun the process for listing its common shares on the NASDAQ Capital Market. This would certainly help liquidity around the stock. Shares leaped on the news, now sitting considerably higher than whenI wrote about them just a few days agoon January 11, 2021. If you don't want to chase, there is a backdoor play open for longer-term investors that I mentioned on Monday. Stay tuned! Draganfly: Drones and a Backdoor Play on Covid-19 If you're looking for an aggressive buy-and-hold in a sector in its infancy, there's a different way to play DFLYF if your time frame fits it. ByTIMOTHY COLLINSJan 11, 2021 | 12:15 PM EST Stocks quotes in this article:DFLYF I talk a lot about time frames. There's a simple explanation: they matter. In fact, they may be the most important deciding factor in not only what you trade but how you trade it. Where is your opportunity? Let's take a look at Draganfly (DFLYF) . This is a small drone company trading on the OTC. Honestly, that's oversimplifying it. Draganfly's business touches way more than drones in the traditional sense. Yes, it recently secured a new drone delivery patent for a vertical take-off and landing cargo delivery drone with variable center of gravity, so there still exists plenty of upside in the traditional sense. The timeframe on this will be longer though as drone delivery won't be on our doorstep, no pun intended, for months, if not years. On the traditional front, it doesn't hurt that the U.S. Department of Agriculture selected Draganfly's Commander Ag-Pro drone for phenotyping, data collection, and data analysis. But many don't realize this company is a backdoor play on Covid-19. The company has partnered with Varigard for Covid-19 disinfecting solutions. We've already seen Alabama State University and Battlefield Fight League (streaming partner of UFC) employ the use of drones plus disinfectant to help open up the world of sports again. The Alabama State Senate is also taking delivery of the Draganfly Vital Intelligence Smart Vital system which monitors (with voluntary consent) vital signs like temperature, heart rate, breathing rate, and blood oxygen content. We're seeing new deals signed pretty much on a weekly basis right now. But what if I told you that you could buy Draganfly shares for $0.47 right now and get a warrant to buy more shares at $0.71 as well. With shares trading north of a buck, it seems like a no-brainer, right? That's where time frame comes into play. In order to buy shares at $0.47 plus get the warrant, an investor needs to be willing to hold the stock and warrant for at least nine months. There's no hedging or other arrangements that can be made unless you want to break a legal contract which no one should do. Here's what this means. If you're playing the stock for the current momentum, this probably won't appeal to you, but how about if you bought the stock around $0.50 initially. Why wouldn't someone consider selling half, then using most of the profits to enter a deal like this? All one would be doing is using profits to rebuy the shares plus get a warrant with those profits. They would actually increase their position while decreasing capital at risk. At worst, they've increased their position size without increasing capital risk. But there's a catch. Isn't there always? If you sold an existing position for a profit, you could owe taxes. That's why I mention using "most" of the profits. Set aside some for taxes if you have to do so. Also, there's the nine month hold. If you have liquidity needs, this wouldn't be a place you could go to get the liquidity you may need. Lastly, there's no guarantee the stock won't be below $0.47 over the next nine months. My view of Draganfly has always been longer term. If the story interests you, I think the open offering is a no-brainer. The biggest challenge is I see fewer and fewer investors with a time horizon of hours or days so even talking about something in terms of months feels dirty and foreign. While this one falls into the highest risk category of investments, getting a 60% downside cushion is rare. Even more, the current intrinsic gain of the deal is $1.14. That's roughly equal to the current stock price! Obviously, that can go away, however, if you're looking for an aggressive buy-and-hold in a sector still in its infancy, there's a different way to play Draganfly if your time frame fits it.
...AND WITH THAT THE STONEDINVESTOR COLLAPSED ONTO HIS LAPTOP HAVING WORKED ALL DAY FOR FREE. TIME TO MAKE SOME SWEET POTATOES.